Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more
Compass Pathways Plc (CMPS) - Total Assets
Latest total assets as of September 2025: $255.61 Million USD
Based on the latest financial reports, Compass Pathways Plc (CMPS) holds total assets worth $255.61 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Compass Pathways Plc - Total Assets Trend (2018–2024)
This chart illustrates how Compass Pathways Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Compass Pathways Plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Compass Pathways Plc's total assets of $255.61 Million consist of 94.2% current assets and 5.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 77.3% |
| Accounts Receivable | $21.82 Million | 10.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Compass Pathways Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Compass Pathways Plc's current assets represent 94.2% of total assets in 2024, a decrease from 99.6% in 2018.
- Cash Position: Cash and equivalents constituted 77.3% of total assets in 2024, down from 86.8% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 10.2% of total assets.
Compass Pathways Plc Competitors by Total Assets
Key competitors of Compass Pathways Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Compass Pathways Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Compass Pathways Plc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Compass Pathways Plc is currently not profitable relative to its asset base.
Compass Pathways Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 8.91 | 29.36 |
| Quick Ratio | 1.23 | 9.41 | 30.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $44.94 Million | $ 207.45 Million | $ 195.51 Million |
Compass Pathways Plc - Advanced Valuation Insights
This section examines the relationship between Compass Pathways Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 20.81 |
| Latest Market Cap to Assets Ratio | 2.08 |
| Asset Growth Rate (YoY) | -22.6% |
| Total Assets | $213.67 Million |
| Market Capitalization | $444.83 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Compass Pathways Plc's assets at a significant premium ( 2.08x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Compass Pathways Plc's assets decreased by 22.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Compass Pathways Plc (2018–2024)
The table below shows the annual total assets of Compass Pathways Plc from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $213.67 Million | -22.58% |
| 2023-12-31 | $275.99 Million | +39.89% |
| 2022-12-31 | $197.29 Million | -34.43% |
| 2021-12-31 | $300.90 Million | +47.89% |
| 2020-12-31 | $203.46 Million | +528.16% |
| 2019-12-31 | $32.39 Million | +22.75% |
| 2018-12-31 | $26.39 Million | -- |